🔗 Share this article

A shadow economy for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust trade exists on Telegram, where groups with thousands of members share comparison photos, injection guides and assertions of next-day British shipping. Sellers promote the drug there before redirecting buyers to other platforms for transactions.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the rising price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

Based on TikTok, the service has taken down violative material and banned related keywords and search suggestions. The company said it was committed to keeping the service safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Investigations also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of members, populated with images of weight loss, positive reviews and step-by-step guides for mixing or administering at home.

Within moments of entering one group, a seller posted contact information, where most transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. Not one inquired about weight, health issues or past usage.

Item Information and Pricing

Inside these groups, messages show dark colored packages with Royal Mail stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually priced at £160 for 20mg. When asked how much time a pen should last, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A representative for the messaging service said it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her team has previously seen individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for personal consumption,” they explained, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially serious health risks”.